Tobramycin-double stranded RNA complex suitable for inducing interferon
AssigneeEli Lilly and Company
InventorsRichard J. Douthart, Walter J. Kleinschmidt, Richard M. Schultz
Life of this patent
Estimating the term…
Abstract
A complex is described which is useful in inducing interferon production, in activating peritoneal macrophages, and in inhibiting the proliferation and migration of tumor cells, which complex comprises natural or synthetic double stranded RNA and tobramycin.
Claims10
A complex comprising (a) natural or synthetic double stranded RNA and (b) tobramycin in a molar ratio of tobramycin to double stranded RNA phosphorus of at least about 1:1.
A pharmaceutical composition suitable for inducing interferon comprising in combination with a pharmaceutically acceptable carrier an interferon-inducing amount of a complex of (a) natural or synthetic double stranded RNA and (b) tobramycin in a molar ratio of tobramycin to double stranded RNA phosphorus of at least about 1:1.
Dependencies are inferred from the claim text.